Brind.

Analysts upgraded stock ratings for several companies, including GCT, Cytokinetics, and Cadence Design Systems, on October 12, 2026.

1 report, 1 independent Updated Mon 00:00

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

Cadence Design Systems Cytokinetics Nasdaq

Keep exploring

The entities involved

Cadence Design Systems
American electronic design automation (EDA) software and engineering services company
- Cadence Design Systems is listed on the Nasdaq exchange.12:10
- A10 Networks and Cadence Design Systems are compared as technology investments while A10 expands its networking solutions across multiple global regions.09:49
Cytokinetics
company in South San Francisco, United States
- MarketBeat reported analyst recommendations for Cytokinetics and Gain Therapeutics, two competing healthcare companies.13:53
- Sung Lee became EVP at Cytokinetics, and Bank of Montreal increased its holdings in the company.08:22
Nasdaq
American fully electronic stock exchange
- Olympus Partners partnered with Accelevation, a Nasdaq-listed company co-founded by Rubiera.14:31
- Anthropic announced that it chose Nasdaq as its IPO venue, while also noting its business model includes revenue sharing with partners like Amazon.14:28

Coverage

Newest first; wire copies grouped

Mon 00:00themarketsdaily.com